Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial.
Jingjing WuLingling DuanLei ZhangZhenchang SunXiaorui FuXin LiLing LiXinhua WangXudong ZhangZhaoming LiHui YuYu ChangFeifei NanJiaqin YanLi TianXiaoli WangMingzhi ZhangPublished in: Journal of neuro-oncology (2018)
FTD chemotherapy appeared to be safe and effective for PCNSL patients. High Bcl-6 expression correlated with longer survival.
Keyphrases
- high dose
- newly diagnosed
- low dose
- stem cell transplantation
- end stage renal disease
- ejection fraction
- clinical trial
- chronic kidney disease
- poor prognosis
- prognostic factors
- open label
- peritoneal dialysis
- randomized controlled trial
- acute myeloid leukemia
- binding protein
- radiation therapy
- long non coding rna
- patient reported